Biohaven Pharmaceutical Holding Company Ltd

(NYSE:BHVN)

Latest On Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Date/Time Type Description Signal Details
2023-05-12 21:12 ESTNewsBiohaven Non-GAAP EPS of -$0.98N/A
2023-03-24 07:34 ESTNewsBiohaven Non-GAAP EPS of -$1.27 beats by $0.01N/A
2023-03-22 08:38 ESTNewsBiohaven acquires rights to potential brain disorder drug BHV-8000 for $10M upfrontN/A
2023-03-10 05:36 ESTNewsBiohaven: Spun And Done - Time To ExitN/A
2023-02-21 22:11 ESTNewsBiohaven's spinal muscular atrophy therapy gets FDA fast track statusN/A
2023-01-04 17:02 ESTNewsBiohaven initiated at overweight at JP Morgan on neurological targetsN/A
2022-12-08 04:49 ESTNewsBiohaven Ltd: Assessing The SpinoffN/A
2022-11-09 21:19 ESTNewsBiohaven Non-GAAP EPS of -$1.25N/A
2022-10-21 04:41 ESTNewsBiohaven prices upsized 25M of stock offering at $10.50/shareN/A
2022-10-18 16:23 ESTNewsBiohaven stock falls 5% after the bell on 20M share offeringN/A
2022-10-07 13:52 ESTNewsBiotech in recovery; but Piper Sandler cites negative fund flowsN/A
2022-10-07 13:49 ESTNewsM&A may be a tailwind for biotech sector into end of year, analyst saysN/A
2022-10-07 13:40 ESTNews'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potentialN/A
2022-10-06 23:49 ESTNewsBiohaven Stub May Provide An Interesting Setup For InvestorsN/A
2022-09-29 23:19 ESTNewsBiohaven says ALS candidate failed in key trialN/A
2022-09-28 00:37 ESTNewsPfizer acquisition of Biohaven Pharmaceuticals expected to close Oct. 3N/A
2022-09-19 19:50 ESTNewsBiohaven announces timeline for spinoffN/A
2022-08-17 15:12 ESTNewsBiohaven: Non-Standard Merger Consideration Makes This A BuyN/A
2022-08-16 05:06 ESTNewsSoros Fund Management takes new stakes in GCP, Biohaven, TeslaN/A
2022-08-05 15:33 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$3.82 misses by $1.57, revenue of $194M misses by $16.6MN/A
2022-07-07 09:59 ESTNewsBiohaven begins enrolling in late-stage trial of spinal muscular atrophy therapyN/A
2022-06-15 23:08 ESTNewsBiohaven Deal: Pfizer Gives Away A FreerollN/A
2022-06-01 11:56 ESTNewsFederal Trade Commission to hold pharma merger and antitrust workshopN/A
2022-05-23 14:53 ESTNewsBiohaven phase 3 trial in genetic muscle disorder fails to reach significance overall due to low disease progressionN/A
2022-05-23 14:53 ESTNewsBiohaven gets FDA review for nasal spray zavegepant to treat migraineN/A
2022-05-11 01:00 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$1.62 beats by $0.65, revenue of $318.85M beats by $135.14MN/A
2022-05-11 01:00 ESTNewsPfizer to acquire Biohaven in ~$11.6B deal; Biohaven stock soars 72%N/A
2022-05-06 21:00 ESTNewsBiohaven Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-27 19:21 ESTNewsPfizer, Biohaven's Vydura gets approval in EU to prevent/treat migraineN/A
2022-04-14 05:28 ESTNewsBiohaven Pharmaceutical: Recent Growth Will ContinueN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$2.32 misses by $0.39, revenue of $190.01M beats by $14.47MN/A
2022-02-26 00:18 ESTNewsBiohaven in licensing pact with Bristol Myers; to acquire Channel BiosciencesN/A
2022-02-26 00:18 ESTNewsPfizer, Biohaven's rimegepant gets EMA panel nod for migraine treatmentN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceutical Holding Company Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-26 00:17 ESTNewsBiohaven Pharmaceutical Holding's (BHVN) CEO Vlad Coric on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-25 05:15 ESTNewsBiohaven Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-22 19:32 ESTNewsBiohaven begins enrollment in phase 2/3 trial of Nurtec ODT in chronic rhinosinusitisN/A
2022-02-15 01:21 ESTNewsPfizer/ Biohaven announce late-stage migraine trial met main goals in Asia PacificN/A
2022-02-01 23:30 ESTNewsNew thematic psychedelic ETF hits the marketN/A
2022-01-28 21:24 ESTNewsAurinia Pharmaceuticals quick uptick on renewed takeover speculation on Biogen newsN/A
2022-01-18 18:11 ESTNewsBiohaven’s Troriluzole to undergo glioblastoma trial designed to study multiple therapiesN/A
2022-01-14 05:01 ESTNewsAurinia Pharmaceuticals reverses decline after report on potential M&A interestN/A
2022-01-10 16:33 ESTNewsBiohaven forms research collaboration to advance TRPM3 antagonists for pain managementN/A
2022-01-06 09:41 ESTNewsBiohaven reports preliminary Q4 Nurtec ODT revenue of $190MN/A
2021-12-07 06:52 ESTNewsBiohaven names Vlad Coric as Chairman, appoints new CFON/A
2021-12-06 12:13 ESTNewsBiohaven says pivotal study for intranasal migraine therapy met main goalsN/A
2021-12-06 12:13 ESTNewsBiohaven names new CEO, CFON/A
2021-11-18 11:13 ESTNewsBiohaven, Artizan to work on Parkinson's drug discovery programN/A
2021-11-17 13:22 ESTNewsBiohaven's migraine med Nurtec approved in KuwaitN/A
2021-11-10 03:44 ESTNewsPfizer to gain ex-U.S. rights to Biohaven migraine med Nurtec in up to $1.24B dealN/A

About Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

BHVN Quotes by TradingView

See Advanced Chart

General

  • Name Biohaven Pharmaceutical Holding Company Ltd
  • Symbol BHVN
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 825
  • Fiscal Year EndDecember
  • IPO Date2017-05-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biohavenpharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 71.25
  • Price/Book (Most Recent Quarter) 31.82
  • Enterprise Value Revenue 73.75
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$10.49
  • Next Year EPS Estimate -$5.57
  • Next Quarter EPS Estimate -$2.73
  • Operating Margin -1014%
  • Return on Assets -78%
  • Revenue 63.63 million
  • Earnings Per Share -$9.14
  • Revenue Per Share $1.08
  • Gross Profit 45.93 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 4.42 billion
  • EBITDA -356321504
  • Analyst Target Price $102.09
  • Book Value Per Share $2.09
View More

Share Statistics

  • Shares Outstanding 61.93 million
  • Shares Float 54.37 million
  • % Held by Insiders 1379%
  • % Held by Institutions 117.55%
  • Shares Short 5.76 million
  • Shares Short Prior Month 5.98 million
  • Short Ratio 11.39
  • Short % of Float 13%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.08
  • 52 Week High $100.77
  • 52 Week Low $28.26
  • 50 Day Moving Average 82.8
  • 200 Day Moving Average 80.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$2.69-$2.56-4.98%
2020-09-302020-11-09$17.66 million-$2.67-$2.866.58%
2020-06-302020-08-10$9.7 million-$2.55-$2.8410.27%
2020-03-312020-05-07$1.15 million-$2.39-$2.462.94%
2019-12-312020-02-25$N/A-$2.85-$1.91-49.31%
2019-09-302019-11-01$N/A-$2.04-$1.57-30.24%
2019-06-302019-08-08$N/A-$4.67-$2.09-123.21%
2019-03-312019-05-07$N/A-$1.41-$1.505.94%
2018-12-312019-02-28$N/A-$1.33-$1.21-10.12%
2018-09-302018-11-14$N/A-$1.53-$1.08-42.33%
2018-06-302018-08-14$N/A-$1.01-$1.053.68%
2018-03-312018-05-15$N/A-$2.32-$1.17-98.29%
2017-12-312018-03-06$N/A-$0.75-$1.3544.34%
2017-09-302017-11-14$N/A-$1.19-$1.243.78%
2017-06-302017-08-14$N/A-$1.78-$0.62-185.94%
2017-03-312017-06-16$N/A-$1.74-$1.45-20%

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Chart:

Biohaven Pharmaceutical Holding Company Ltd (BHVN) News:

Below you will find a list of latest news for Biohaven Pharmaceutical Holding Company Ltd (BHVN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-03-212018.4CALL0 1128.89TRUE00
2025-03-2122.50CALL0 0115.61TRUE00
2025-03-212514.4CALL0 0106.85TRUE00
2025-03-2127.50CALL0 095.47TRUE00
2025-03-21309.9CALL0 382.69TRUE00
2025-03-2132.50CALL0 068.89TRUE00
2025-03-21358.1CALL0 1777.31TRUE00
2025-03-2137.54.3CALL2 2068.06TRUE4.30
2025-03-21403.27CALL4 60474.2FALSE-0.03-0.01
2025-03-2142.52.1CALL1 32170.07FALSE-0.25-0.11
2025-03-21451.48CALL27 13772.48FALSE-0.12-0.08
2025-03-2147.51.21CALL10 8379.45FALSE1.210
2025-03-21501.35CALL0 16390.69FALSE00
2025-03-21551.44CALL0 1111.79FALSE00
2025-03-21200PUT0 0218.12FALSE00
2025-03-2122.50.8PUT0 4189.24FALSE00
2025-03-21250PUT0 0163.16FALSE00
2025-03-2127.50PUT0 0141.3FALSE00
2025-03-21301PUT0 17120.43FALSE00
2025-03-2132.50.7PUT2 39676.3FALSE0.70
2025-03-21351.65PUT4 13485.41FALSE1.650
2025-03-2137.52.5PUT2 22782.42FALSE-0.25-0.09
2025-03-21404PUT2 36788.31TRUE0.30.08
2025-03-2142.55.6PUT0 2782.61TRUE00
2025-03-21456.5PUT10 2870.48TRUE6.50
2025-03-2147.57.6PUT0 274.94TRUE00
2025-03-21500PUT0 075.39TRUE00
2025-03-21550PUT0 071.79TRUE00
2025-04-17200CALL0 097.66TRUE00
2025-04-1722.50CALL0 094.43TRUE00
2025-04-17250CALL0 092.49TRUE00
2025-04-173013.3CALL0 684.08TRUE00
2025-04-173510.17CALL0 14887.43TRUE00
2025-04-17405.41CALL1 30087.22FALSE5.410
2025-04-1742.56.63CALL0 7881.25FALSE00
2025-04-17453.4CALL15 193384.08FALSE0.40.13
2025-04-1747.52.47CALL0 12580.72FALSE00
2025-04-17502.59CALL0 11080.08FALSE00
2025-04-1752.51.75CALL0 12086.21FALSE00
2025-04-17551.65CALL0 7288.26FALSE00
2025-04-1757.51.35CALL0 10989.03FALSE00
2025-04-17600.95CALL0 27887.09FALSE00
2025-04-1762.53.6CALL0 2099.99FALSE00
2025-04-17652.3CALL0 29104.86FALSE00
2025-04-17701.75CALL0 137113.58FALSE00
2025-04-17751.55CALL0 6121.18FALSE00
2025-04-17803.6CALL0 11129.35FALSE00
2025-04-17200.65PUT0 10159.75FALSE00
2025-04-1722.50.74PUT0 14140.64FALSE00
2025-04-17250PUT0 0121.44FALSE00
2025-04-17301PUT0 3282.46FALSE00
2025-04-17352.36PUT0 19384.95FALSE00
2025-04-17405.6PUT3 15290.59TRUE5.60
2025-04-1742.57.3PUT0 1384.08TRUE00
2025-04-17458.6PUT0 3588.73TRUE00
2025-04-1747.58.3PUT0 1581.82TRUE00
2025-04-175014.8PUT0 3383.66TRUE00
2025-04-1752.513.9PUT0 380.51TRUE00
2025-04-175510.5PUT0 1776.58TRUE00
2025-04-1757.512.5PUT0 2977.83TRUE00
2025-04-176025.95PUT0 1179.12TRUE00
2025-04-1762.518PUT0 1678.98TRUE00
2025-04-176517.1PUT0 2076.45TRUE00
2025-04-17700PUT0 0147.38TRUE00
2025-04-17750PUT0 0157.74TRUE00
2025-04-17800PUT0 091.52TRUE00
2025-07-182019CALL0 1571.67TRUE00
2025-07-1822.50CALL0 077.95TRUE00
2025-07-18250CALL0 076.98TRUE00
2025-07-1827.50CALL0 072.05TRUE00
2025-07-183013CALL0 175.85TRUE00
2025-07-1832.511.42CALL3 275.63TRUE11.420
2025-07-18359.6CALL2 370.37TRUE9.60
2025-07-1837.58.74CALL10 874.55TRUE8.740
2025-07-18408.26CALL0 24379.65FALSE00
2025-07-1842.56.9CALL0 5474.62FALSE00
2025-07-18455.52CALL0 9579.53FALSE00
2025-07-1847.55.7CALL0 2774.01FALSE00
2025-07-18505.2CALL0 7869.42FALSE00
2025-07-1852.54.1CALL0 971.04FALSE00
2025-07-18553.7CALL0 3569.76FALSE00
2025-07-1857.53.9CALL0 168.74FALSE00
2025-07-18602.26CALL0 164.91FALSE00
2025-07-18652CALL0 25368.83FALSE00
2025-07-18701.9CALL0 9765.02FALSE00
2025-07-18201PUT0 1102.77FALSE00
2025-07-1822.50PUT0 092.89FALSE00
2025-07-18251.1PUT0 3988.29FALSE00
2025-07-1827.51.9PUT0 271.39FALSE00
2025-07-18302.65PUT10 10375.47FALSE2.650
2025-07-1832.51.55PUT1 1380.8FALSE1.550
2025-07-18355.2PUT0 3276.02FALSE00
2025-07-1837.56PUT5 9375.98FALSE0.10.02
2025-07-18407PUT6 1671.99TRUE70
2025-07-1842.58.5PUT0 1073.91TRUE00
2025-07-18459PUT0 22074.11TRUE00
2025-07-1847.511.2PUT0 174.24TRUE00
2025-07-18500PUT0 072.88TRUE00
2025-07-1852.50PUT0 072.11TRUE00
2025-07-18550PUT0 070.39TRUE00
2025-07-1857.50PUT0 074.18TRUE00
2025-07-18600PUT0 066.74TRUE00
2025-07-18650PUT0 066.99TRUE00
2025-07-18700PUT0 065.74TRUE00
2025-10-1722.50CALL0 076.95TRUE00
2025-10-17250CALL0 075.26TRUE00
2025-10-1727.50CALL0 079.1TRUE00
2025-10-17300CALL0 076.27TRUE00
2025-10-1732.50CALL0 074.2TRUE00
2025-10-17350CALL0 074.97TRUE00
2025-10-1737.50CALL0 076.4TRUE00
2025-10-17400CALL0 073.53FALSE00
2025-10-1742.50CALL0 075.28FALSE00
2025-10-17450CALL0 073.9FALSE00
2025-10-1747.50CALL0 073.1FALSE00
2025-10-17500CALL0 072.89FALSE00
2025-10-17550CALL0 070.5FALSE00
2025-10-1722.50PUT0 080.1FALSE00
2025-10-17250PUT0 074.15FALSE00
2025-10-1727.50PUT0 074.93FALSE00
2025-10-17300PUT0 075.9FALSE00
2025-10-1732.50PUT0 074.42FALSE00
2025-10-17350PUT0 075.66FALSE00
2025-10-1737.50PUT0 074.9FALSE00
2025-10-17400PUT0 074.96TRUE00
2025-10-1742.50PUT0 074.62TRUE00
2025-10-17450PUT0 073.97TRUE00
2025-10-1747.50PUT0 073.06TRUE00
2025-10-17500PUT0 072.72TRUE00
2025-10-17550PUT0 070.73TRUE00
2025-12-1917.523.2CALL0 5177.75TRUE00
2025-12-192020.5CALL0 4078.16TRUE00
2025-12-1922.519CALL0 476.45TRUE00
2025-12-192516.5CALL0 276.09TRUE00
2025-12-193014.42CALL0 1072.92TRUE00
2025-12-19359.6CALL0 1775.51TRUE00
2025-12-194010.3CALL0 17177.54FALSE00
2025-12-1942.510.18CALL147 47675.03FALSE0.270.03
2025-12-19459.67CALL0 15473.44FALSE00
2025-12-1947.50CALL0 071.62FALSE00
2025-12-19507CALL0 40472.15FALSE00
2025-12-1952.50CALL0 071.9FALSE00
2025-12-19555.5CALL0 1969.87FALSE00
2025-12-1957.50CALL0 069.56FALSE00
2025-12-19607CALL0 2869.63FALSE00
2025-12-1962.50CALL0 069.94FALSE00
2025-12-19655.8CALL0 867.72FALSE00
2025-12-197010.63CALL0 166.88FALSE00
2025-12-19750CALL0 064.9FALSE00
2025-12-19800CALL0 068.37FALSE00
2025-12-1917.51PUT1 3778.37FALSE10
2025-12-19204.34PUT0 193.85FALSE00
2025-12-1922.52.9PUT0 8473.36FALSE00
2025-12-19252.8PUT0 12072.3FALSE00
2025-12-19304.6PUT0 1376.88FALSE00
2025-12-19355.52PUT0 11273.07FALSE00
2025-12-194010.47PUT0 3072.13TRUE00
2025-12-1942.510.01PUT0 172.86TRUE00
2025-12-194512.2PUT0 171.91TRUE00
2025-12-1947.512.09PUT0 171.84TRUE00
2025-12-195018.8PUT0 1073.72TRUE00
2025-12-1952.50PUT0 072.36TRUE00
2025-12-19550PUT0 071.97TRUE00
2025-12-1957.50PUT0 073.35TRUE00
2025-12-19600PUT0 072.23TRUE00
2025-12-1962.50PUT0 070.29TRUE00
2025-12-19650PUT0 069.05TRUE00
2025-12-19700PUT0 069.29TRUE00
2025-12-19750PUT0 069.66TRUE00
2025-12-19800PUT0 067.72TRUE00
2026-01-162021.64CALL0 180.6TRUE00
2026-01-1622.50CALL0 077.93TRUE00
2026-01-162518.75CALL0 278.01TRUE00
2026-01-163018.5CALL0 574.79TRUE00
2026-01-163510.2CALL0 7074.2TRUE00
2026-01-1637.511.2CALL0 174.52TRUE00
2026-01-164010.7CALL1 16068.83FALSE10.70
2026-01-1642.510.7CALL0 171.93FALSE00
2026-01-16459CALL0 18973FALSE00
2026-01-1647.50CALL0 070.22FALSE00
2026-01-16508.2CALL0 19471.72FALSE00
2026-01-1652.56.6CALL0 168.18FALSE00
2026-01-16556.8CALL0 267.25FALSE00
2026-01-1657.50CALL0 069.67FALSE00
2026-01-16600CALL0 071.15FALSE00
2026-01-16650CALL0 067.62FALSE00
2026-01-16200PUT0 088.57FALSE00
2026-01-1622.50PUT0 078.66FALSE00
2026-01-16250PUT0 079.01FALSE00
2026-01-16304.1PUT0 172.52FALSE00
2026-01-16357.3PUT0 874.58FALSE00
2026-01-1637.50PUT0 073.17FALSE00
2026-01-164010PUT0 271.93TRUE00
2026-01-1642.50PUT0 071.9TRUE00
2026-01-16450PUT0 070.64TRUE00
2026-01-1647.50PUT0 072.27TRUE00
2026-01-16500PUT0 071.09TRUE00
2026-01-1652.50PUT0 071.83TRUE00
2026-01-16550PUT0 069.12TRUE00
2026-01-1657.50PUT0 070.14TRUE00
2026-01-16600PUT0 069.8TRUE00
2026-01-16650PUT0 067.59TRUE00
2026-12-18200CALL0 068.96TRUE00
2026-12-1822.50CALL0 068.24TRUE00
2026-12-18250CALL0 066.82TRUE00
2026-12-183019.5CALL0 266.13TRUE00
2026-12-18350CALL0 066.54TRUE00
2026-12-1837.50CALL0 065.53TRUE00
2026-12-184012.5CALL0 165.6FALSE00
2026-12-1842.50CALL0 064.05FALSE00
2026-12-184514.75CALL0 3063.06FALSE00
2026-12-1847.50CALL0 064.06FALSE00
2026-12-18500CALL0 062.38FALSE00
2026-12-1852.50CALL0 062.91FALSE00
2026-12-18550CALL0 062.29FALSE00
2026-12-1857.50CALL0 061.26FALSE00
2026-12-18600CALL0 061.24FALSE00
2026-12-18650CALL0 061.92FALSE00
2026-12-18200PUT0 070.38FALSE00
2026-12-1822.50PUT0 066.42FALSE00
2026-12-18255.9PUT0 266.48FALSE00
2026-12-18300PUT0 067.8FALSE00
2026-12-18350PUT0 066.98FALSE00
2026-12-1837.50PUT0 064.47FALSE00
2026-12-184010.25PUT0 3064.42TRUE00
2026-12-1842.50PUT0 064.03TRUE00
2026-12-18450PUT0 063.34TRUE00
2026-12-1847.50PUT0 063.6TRUE00
2026-12-18500PUT0 065.54TRUE00
2026-12-1852.50PUT0 061.92TRUE00
2026-12-18550PUT0 062.88TRUE00
2026-12-1857.50PUT0 063.36TRUE00
2026-12-18600PUT0 063.66TRUE00
2026-12-18650PUT0 061.57TRUE00
2027-01-152023.8CALL0 170.28TRUE00
2027-01-1522.50CALL0 067.84TRUE00
2027-01-152521.9CALL0 569.5TRUE00
2027-01-153020.25CALL0 367.79TRUE00
2027-01-153514.75CALL0 662.35TRUE00
2027-01-1537.512.7CALL0 064.51TRUE00
2027-01-154015.35CALL0 6065.35FALSE00
2027-01-1542.514.35CALL0 4063.03FALSE00
2027-01-15450CALL0 064.02FALSE00
2027-01-1547.50CALL0 062.55FALSE00
2027-01-15500CALL0 062.57FALSE00
2027-01-1552.50CALL0 061.44FALSE00
2027-01-15558.75CALL0 061.99FALSE00
2027-01-1557.59CALL0 161.9FALSE00
2027-01-15607.85CALL0 361.65FALSE00
2027-01-15657.7CALL0 1061.87FALSE00
2027-01-15202.6PUT0 164.75FALSE00
2027-01-1522.53.7PUT0 260.76FALSE00
2027-01-15250PUT0 069.81FALSE00
2027-01-15308.43PUT0 165.7FALSE00
2027-01-15358.7PUT0 165.88FALSE00
2027-01-1537.510.64PUT0 1065.59FALSE00
2027-01-154012.41PUT0 1063.4TRUE00
2027-01-1542.512.3PUT0 163.03TRUE00
2027-01-15450PUT0 064.08TRUE00
2027-01-1547.50PUT0 064.09TRUE00
2027-01-15500PUT0 062.42TRUE00
2027-01-1552.50PUT0 063.38TRUE00
2027-01-15550PUT0 061.25TRUE00
2027-01-1557.50PUT0 062.45TRUE00
2027-01-15600PUT0 062.77TRUE00
2027-01-15650PUT0 062.93TRUE00

Latest BHVN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST40$143.84
Jun 13, 2022 7:59 PM EST9$143.84
Jun 13, 2022 7:59 PM EST8$143.87
Jun 13, 2022 7:59 PM EST100$143.87
Jun 13, 2022 7:59 PM EST3$143.83

Biohaven Pharmaceutical Holding Company Ltd (BHVN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719006904/0000215457-19-006904-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719008296/0000215457-19-008296-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720008248/0000834237-20-008248-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720009073/0000834237-20-009073-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465918071968/0001104659-18-071968-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919015412/0001104659-19-015412-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919020231/0001104659-19-020231-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027408/0001104659-19-027408-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027610/0001104659-19-027610-index.htm
2019-08-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000110465919046550/0001104659-19-046550-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920003210/0001104659-20-003210-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920009364/0001104659-20-009364-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920027268/0001104659-20-027268-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920041258/0001104659-20-041258-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047706/0001104659-20-047706-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047741/0001104659-20-047741-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000114420419008285/0001144204-19-008285-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010164/0001209191-19-010164-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010166/0001209191-19-010166-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010174/0001209191-19-010174-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010177/0001209191-19-010177-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010184/0001209191-19-010184-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010209/0001209191-19-010209-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010214/0001209191-19-010214-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023434/0001209191-19-023434-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023435/0001209191-19-023435-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2019-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032463/0001209191-19-032463-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032465/0001209191-19-032465-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032466/0001209191-19-032466-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032468/0001209191-19-032468-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032470/0001209191-19-032470-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032472/0001209191-19-032472-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039783/0001209191-19-039783-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039785/0001209191-19-039785-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417319000086/0001274173-19-000086-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417320000063/0001274173-20-000063-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001022/0001410578-19-001022-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001524/0001410578-19-001524-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006297/0001562180-19-006297-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-01-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000722/0001562180-20-000722-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000723/0001562180-20-000723-index.htm
2020-03-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002440/0001562180-20-002440-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003254/0001562180-20-003254-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003255/0001562180-20-003255-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003256/0001562180-20-003256-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003257/0001562180-20-003257-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003258/0001562180-20-003258-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004469/0001562180-20-004469-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004470/0001562180-20-004470-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-123/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004473/0001562180-20-004473-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000002/0001562230-20-000002-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000003/0001562230-20-000003-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000161577419002508/0001615774-19-002508-index.htm
2018-12-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1689813/000162828018014980/0001628280-18-014980-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014982/0001628280-18-014982-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014985/0001628280-18-014985-index.htm
2018-12-12S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015071/0001628280-18-015071-index.htm
2018-12-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015109/0001628280-18-015109-index.htm
2019-06-17S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008046/0001628280-19-008046-index.htm
2019-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008061/0001628280-19-008061-index.htm
2019-06-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008196/0001628280-19-008196-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008232/0001628280-19-008232-index.htm
2020-01-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000632/0001628280-20-000632-index.htm
2020-01-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000742/0001628280-20-000742-index.htm
2020-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828020000788/0001628280-20-000788-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981318000042/0001689813-18-000042-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000047/0001689813-18-000047-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000049/0001689813-18-000049-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000010/0001689813-19-000010-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000014/0001689813-19-000014-index.htm
2019-04-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000020/0001689813-19-000020-index.htm
2019-04-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000022/0001689813-19-000022-index.htm
2019-05-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000026/0001689813-19-000026-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000030/0001689813-19-000030-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000034/0001689813-19-000034-index.htm
2019-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000044/0001689813-19-000044-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000046/0001689813-19-000046-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000052/0001689813-19-000052-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000055/0001689813-19-000055-index.htm
2019-08-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000056/0001689813-19-000056-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000066/0001689813-19-000066-index.htm
2019-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000088/0001689813-19-000088-index.htm
2019-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000089/0001689813-19-000089-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000106/0001689813-19-000106-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000107/0001689813-19-000107-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000108/0001689813-19-000108-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000109/0001689813-19-000109-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000110/0001689813-19-000110-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000111/0001689813-19-000111-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000112/0001689813-19-000112-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000113/0001689813-19-000113-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000130/0001689813-19-000130-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000014/0001689813-20-000014-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000016/0001689813-20-000016-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000022/0001689813-20-000022-index.htm
2020-03-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000027/0001689813-20-000027-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000030/0001689813-20-000030-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000040/0001689813-20-000040-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000042/0001689813-20-000042-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000044/0001689813-20-000044-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000046/0001689813-20-000046-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000049/0001689813-20-000049-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000053/0001689813-20-000053-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000057/0001689813-20-000057-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000063/0001689813-20-000063-index.htm
2018-12-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1689813/999999999518003115/9999999995-18-003115-index.htm

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Pharmaceutical Holding Company Ltd (BHVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1379%
Institutional Ownership: 11755%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-15Elyse StockChief Medical OfficerSell800.0045.0136,008.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-18Elyse StockChief Medical OfficerSell17,700.0045.07797,749.620.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-02-04ERIC AGUIARDirectorSell17,609.0042.54749,086.860.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorSell10,000.0045.00450,000.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-11-20ERIC AGUIARDirectorSell6,729.0052.20351,234.290.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-22ERIC AGUIARDirectorSell1,250.0055.2469,050.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-09ERIC AGUIARDirectorSell4,072.0055.11224,410.770.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-16ERIC AGUIARDirectorSell3,537.0055.13194,984.550.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-01-10John TiltonChief Commercial OfficerSell10,500.0037.67395,535.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-12John TiltonChief Commercial OfficerSell10,000.0050.11501,100.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-02-21JULIA P GREGORYDirectorSell12,000.0043.56522,720.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorSell12,000.0054.75656,956.800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsSell3,935.0053.03208,665.180.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsSell21,065.0053.041,117,205.450.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-01-09ERIC AGUIARDirectorSell30,000.0056.391,691,700.000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2019-02-04ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-03-12John TiltonChief Commercial OfficerBuy10,000.009.2992,900.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-06-26JOHN W CHILDSDirectorBuy10,000.0040.37403,700.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-03-26Declan DooganDirectorSell5,824.0053.72312,865.281,014,827.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-22Declan DooganDirectorSell5,351.0053.66287,134.661,020,651.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-01Declan DooganDirectorSell50,000.0047.192,359,500.001,026,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-01-10John TiltonChief Commercial OfficerBuy10,500.009.2997,545.0010,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-22JOHN W CHILDSDirectorBuy107,500.009.29998,675.00107,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-03-01Declan DooganDirectorSell595.0045.4127,018.951,076,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-27Declan DooganDirectorSell23,384.0045.711,068,882.641,076,597.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Vlad CoricChief Executive OfficerBuy10,950.0010,950.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-02-25Declan DooganDirectorSell13,943.0045.49634,267.071,099,981.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-19Declan DooganDirectorSell1,400.0045.5163,714.001,113,924.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-15Declan DooganDirectorSell678.0045.4230,794.761,115,324.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-13Declan DooganDirectorSell6,158.0044.24272,429.921,116,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-12Declan DooganDirectorSell33,842.0044.321,499,877.441,122,160.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2018-12-03Declan DooganDirectorSell40,000.0041.951,678,000.001,156,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-02-21JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-18John TiltonCCO-Rare & Neurologic DisorderBuy1,250.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2020-01-08ERIC AGUIARDirectorBuy1,250.0055.9169,887.501,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-22ERIC AGUIARDirectorSell150.0058.868,828.601,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtBuy125,000.000.6176,250.00125,341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-12Elyse StockChief Medical OfficerSell15,925.0064.891,033,347.7713,234.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtBuy986.000.61601.461,327.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-11James EngelhartChief Financial OfficerSell4,847.0063.19306,286.2913,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell200.0058.0011,599.001,400.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy11,453.009.29106,398.3715,975.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell671.0056.9938,243.181,600.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell59,914.0075.254,508,822.081,741.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell1,300.0077.70101,005.061,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2019-02-04ERIC AGUIARDirectorBuy7,609.0020.79158,191.1117,609.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-10-18Elyse StockChief Medical OfficerBuy17,700.0010.82191,514.0017,700.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2020-06-11James EngelhartChief Financial OfficerSell5,972.0062.07370,697.5718,322.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-12Elyse StockChief Medical OfficerSell11,390.0065.80749,497.311,844.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-06-26Vlad CoricChief Executive OfficerBuy5,000.0040.22201,100.0019,130.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2020-01-22ERIC AGUIARDirectorBuy771.0032.4224,995.822,021.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsBuy21,065.000.6112,849.6521,065.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell5,261.0075.62397,843.6621,878.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy20,716.0020.79430,685.6422,560.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0055.9927,995.502,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-06-27Robert BermanChief Medical OfficerBuy2,500.0042.30105,750.00240,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2020-06-11James EngelhartChief Financial OfficerBuy19,772.009.29183,681.8824,294.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-04-07JOHN W CHILDSDirectorSell14,734.0033.26490,119.142,476,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-08-11JOHN W CHILDSDirectorBuy2,600.0060.32156,823.942,479,538.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-08-11JOHN W CHILDSDirectorBuy7,271.0061.28445,567.612,486,809.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-04-07JOHN W CHILDSDirectorSell93,268.0032.923,070,130.742,491,672.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2019-06-27James EngelhartChief Financial OfficerBuy2,500.0043.05107,625.002,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2020-08-11JOHN W CHILDSDirectorBuy15,129.0061.87936,093.262,501,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-11JOHN W CHILDSDirectorBuy6,678.0059.00393,983.972,508,616.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-21JOHN W CHILDSDirectorBuy3,322.0059.25196,828.502,511,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-23Gregory BaileyDirectorSell212.0079.9416,948.002,545,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-23Gregory BaileyDirectorSell10,191.0078.89803,918.052,545,870.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell3,100.0079.88247,632.032,556,061.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell21,466.0079.411,704,720.242,559,161.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-19Gregory BaileyDirectorSell4,554.0078.98359,655.342,580,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-03-25Gregory BaileyDirectorBuy107,500.009.29998,675.002,582,601.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2020-04-07JOHN W CHILDSDirectorSell10,908.0031.55344,196.492,584,940.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-10-16Gregory BaileyDirectorSell3,748.0078.88295,638.122,585,181.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-08-20Gregory BaileyDirectorBuy5,000.0037.65188,250.002,587,601.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2020-10-12Gregory BaileyDirectorSell6,729.0078.87530,740.452,588,929.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-07-08Gregory BaileyDirectorSell5,991.0075.93454,888.242,595,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-04-07JOHN W CHILDSDirectorSell81,090.0030.542,476,585.912,595,848.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-07-08Gregory BaileyDirectorSell44,009.0075.123,305,876.862,601,649.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-06-24Gregory BaileyDirectorSell2,395.0070.24168,224.802,645,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-24Gregory BaileyDirectorSell1,600.0069.29110,864.962,648,053.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell835.0075.1862,779.312,649,653.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell63,257.0074.604,719,256.862,650,488.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-04-06JOHN W CHILDSDirectorSell5,341.0031.76169,626.962,676,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-04-06JOHN W CHILDSDirectorSell144,659.0031.234,517,309.992,682,279.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-06-23Gregory BaileyDirectorSell24,084.0073.721,775,368.922,713,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsBuy23,500.009.29218,315.0027,139.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-23Gregory BaileyDirectorSell13,467.0072.70979,026.662,737,829.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-22Gregory BaileyDirectorSell49,132.0073.643,618,011.702,751,296.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy24,000.005.60134,400.0027,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0054.9727,485.852,771.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-05Gregory BaileyDirectorBuy212,500.000.61129,625.002,800,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-22Gregory BaileyDirectorSell20,659.0072.911,506,202.242,800,428.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-22Gregory BaileyDirectorSell10,540.0072.01758,961.162,821,087.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell428.0075.2232,193.392,831,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell22,584.0073.781,666,267.852,832,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell12,157.0072.93886,618.522,854,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell21,798.0071.981,568,935.032,866,796.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell58,238.0070.914,129,854.592,888,594.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-12Elyse StockChief Medical OfficerSell5,300.0064.05339,448.0429,159.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Gregory BaileyDirectorSell26,814.0070.101,879,792.792,946,832.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy150,000.005.60840,000.002,950,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-10James EngelhartChief Financial OfficerSell28,821.0066.661,921,135.8129,654.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-19Gregory BaileyDirectorSell22,012.0069.011,519,094.352,973,646.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy37,700.009.29350,233.002,987,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2019-12-18WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy3,000.003,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2020-01-09ERIC AGUIARDirectorBuy30,000.009.29278,700.0030,000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-06-05Gregory BaileyDirectorBuy20,000.0010.82216,400.003,007,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-05Gregory BaileyDirectorBuy18,000.0028.76517,680.003,025,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy1,000.0037.5437,540.003,049.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell4,010.0077.01308,799.273,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell55,626.0075.254,185,745.253,119.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-10John TiltonChief Commercial OfficerSell21,364.0066.701,425,036.4831,406.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy30,000.0050.721,521,600.0031,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-10John TiltonChief Commercial OfficerSell5,331.0068.57365,528.013,237.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-01-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.003,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy17,500.000.6110,675.0033,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Elyse StockChief Medical OfficerBuy3,375.003,375.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell300.0055.9716,791.00341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell1,400.0076.05106,467.48341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtSell986.0075.0774,015.96341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtSell4,296.0075.05322,431.12341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell2,778.0075.29209,144.51341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-12Elyse StockChief Medical OfficerSell4,351.0063.02274,208.7234,459.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-12-16ERIC AGUIARDirectorBuy3,537.0020.7973,534.233,537.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy590.0020.7912,266.103,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsSell600.0070.0542,027.483,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsSell24,000.0070.201,684,869.603,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell2,458.0077.42190,300.083,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy36,314.000.6122,151.5436,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-02-27Declan DooganDirectorSell1,900.0045.8687,134.00373,913.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Kimberly GentileSVP, Clinical OperationsBuy3,750.003,750.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-02-27Declan DooganDirectorSell18,270.0045.25826,717.50375,813.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy16,250.0032.42526,825.0038,810.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsBuy3,935.000.612,400.353,935.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-02-27Declan DooganDirectorSell6,875.0044.17303,668.75394,083.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-26Declan DooganDirectorSell100.0044.814,481.00400,958.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-26Declan DooganDirectorSell20,796.0044.31921,470.76401,058.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy400.005.602,240.004,039.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2019-12-09ERIC AGUIARDirectorBuy4,072.0020.7984,656.884,072.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell53,762.0053.432,872,449.904,129.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-02-25Declan DooganDirectorSell100.0045.744,574.00421,854.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-25Declan DooganDirectorSell20,334.0045.25920,113.50421,954.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsBuy600.005.603,360.004,239.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell15,783.0050.03789,623.49440,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell16,050.0044.97721,768.50442,288.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-10James EngelhartChief Financial OfficerSell300.0068.0720,420.014,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-11James EngelhartChief Financial OfficerSell2,452.0064.85159,015.394,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell8,262.0050.02413,265.24455,783.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell5,575.0044.11245,913.25458,338.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtBuy4,296.000.612,620.564,637.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell25,955.0050.151,301,643.25464,045.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell16,110.0050.02805,822.20475,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10James EngelhartChief Financial OfficerSell24,832.0067.531,676,989.394,822.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell7,883.0050.02394,307.66491,110.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell26,007.0050.151,304,251.05498,993.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10John TiltonChief Commercial OfficerBuy52,000.009.29483,080.0052,770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell67,450.0052.953,571,349.3557,891.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy25,000.005.60140,000.0058,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtBuy58,404.000.6135,626.4458,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell15,781.0076.421,205,938.266,097.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy25,000.005.60140,000.0061,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-12-18James EngelhartChief Financial OfficerBuy3,700.006,200.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-18Robert BermanSpecial Projects & Med OvrsghtBuy625.00625.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-06-16Declan DooganDirectorSell300.0069.4220,825.01626,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-16Declan DooganDirectorSell25,208.0068.731,732,457.61626,302.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell3,488.0054.89191,462.25641.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-16Declan DooganDirectorSell31,920.0067.902,167,514.83651,510.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-11-20ERIC AGUIARDirectorBuy6,729.0032.42218,154.186,729.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2020-06-16Declan DooganDirectorSell2,572.0066.94172,161.71683,430.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell15,797.0068.101,075,800.98686,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-11James EngelhartChief Financial OfficerSell6,501.0064.31418,057.866,974.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Charles ConwayChief Scientific OfficerBuy3,000.007,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2020-06-15Declan DooganDirectorSell18,703.0067.511,262,557.24701,799.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell24,690.0076.021,876,872.087,065.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-15Declan DooganDirectorSell34,336.0066.052,267,872.20720,502.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell11,164.0065.62732,560.47754,838.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-12Declan DooganDirectorSell25,914.0065.781,704,749.90766,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell2,467.0069.40171,201.91770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-12Declan DooganDirectorSell28,086.0064.791,819,683.51791,916.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-10-15Elyse StockChief Medical OfficerBuy800.0010.828,656.00800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2020-06-12Declan DooganDirectorSell18,400.0063.901,175,767.36820,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-12Declan DooganDirectorSell7,600.0062.93478,252.04838,402.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell25,039.0064.571,616,873.39846,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell22,838.0067.531,542,234.158,568.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-11Declan DooganDirectorSell18,474.0063.791,178,530.36871,041.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell20,043.0062.781,258,207.34889,515.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell16,444.0061.971,018,988.64909,558.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-04-16Declan DooganDirectorSell50,000.0061.923,096,000.00926,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2020-01-08Elyse StockChief Medical OfficerBuy937.0055.9152,387.67937.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2019-04-12Declan DooganDirectorSell38,825.0053.922,093,444.00976,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm